These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 30796149)
1. Implications of Transitional Care Interventions on Hospital Readmissions in Patients With Destination Therapy Left Ventricular Assist Devices. Iseler JI; Wierenga KL; Shaid EC; Hirschman K Res Theory Nurs Pract; 2019 Feb; 33(1):81-96. PubMed ID: 30796149 [TBL] [Abstract][Full Text] [Related]
2. Performance Improvement to Decrease Readmission Rates for Patients With a Left Ventricular Assist Device. Iseler J; Fox J; Wierenga K Prog Transplant; 2018 Jun; 28(2):184-188. PubMed ID: 29558876 [TBL] [Abstract][Full Text] [Related]
3. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study. Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434 [TBL] [Abstract][Full Text] [Related]
4. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation. Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098 [TBL] [Abstract][Full Text] [Related]
5. Transitional care programs improve outcomes for heart failure patients: an integrative review. Stamp KD; Machado MA; Allen NA J Cardiovasc Nurs; 2014; 29(2):140-54. PubMed ID: 23348223 [TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure. Baras Shreibati J; Goldhaber-Fiebert JD; Banerjee D; Owens DK; Hlatky MA JACC Heart Fail; 2017 Feb; 5(2):110-119. PubMed ID: 28017351 [TBL] [Abstract][Full Text] [Related]
7. Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival. Smedira NG; Hoercher KJ; Lima B; Mountis MM; Starling RC; Thuita L; Schmuhl DM; Blackstone EH JACC Heart Fail; 2013 Feb; 1(1):31-9. PubMed ID: 24621797 [TBL] [Abstract][Full Text] [Related]
8. Readmissions after left ventricular assist device implantation: Considerations for nurse practitioners. Kaiser JA J Am Assoc Nurse Pract; 2019 Jul; 31(7):396-402. PubMed ID: 30829965 [TBL] [Abstract][Full Text] [Related]
9. Outcomes and Predictors of Readmissions with GI Bleeding in Patients with Left Ventricular Assist Devices. Shah R; Qayed E South Med J; 2018 Nov; 111(11):666-673. PubMed ID: 30392001 [TBL] [Abstract][Full Text] [Related]
10. [Left Ventricular Assist Device Therapy - Ways to Improve the Ambulatory Care]. Burkhard-Meier C; Morshuis M Dtsch Med Wochenschr; 2018 Mar; 143(5):349-353. PubMed ID: 29232736 [TBL] [Abstract][Full Text] [Related]
11. Dying With a Left Ventricular Assist Device as Destination Therapy. Dunlay SM; Strand JJ; Wordingham SE; Stulak JM; Luckhardt AJ; Swetz KM Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758809 [TBL] [Abstract][Full Text] [Related]
13. Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management). Stehlik J; Estep JD; Selzman CH; Rogers JG; Spertus JA; Shah KB; Chuang J; Farrar DJ; Starling RC; Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611126 [TBL] [Abstract][Full Text] [Related]
14. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment. Health Quality Ontario Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798 [TBL] [Abstract][Full Text] [Related]
15. Economic Evaluation of Left Ventricular Assist Devices for Patients With End Stage Heart Failure Who Are Ineligible for Cardiac Transplantation. Chew DS; Manns B; Miller RJH; Sharma N; Exner DV Can J Cardiol; 2017 Oct; 33(10):1283-1291. PubMed ID: 28941608 [TBL] [Abstract][Full Text] [Related]
16. Palliative Medicine and Preparedness Planning for Patients Receiving Left Ventricular Assist Device as Destination Therapy-Challenges to Measuring Impact and Change in Institutional Culture. Verdoorn BP; Luckhardt AJ; Wordingham SE; Dunlay SM; Swetz KM J Pain Symptom Manage; 2017 Aug; 54(2):231-236. PubMed ID: 28093312 [TBL] [Abstract][Full Text] [Related]
17. Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates. Imamura T; Jeevanandam V; Kim G; Raikhelkar J; Sarswat N; Kalantari S; Smith B; Rodgers D; Besser S; Chung B; Nguyen A; Narang N; Ota T; Song T; Juricek C; Mehra M; Costanzo MR; Jorde UP; Burkhoff D; Sayer G; Uriel N Circ Heart Fail; 2019 Feb; 12(2):e005094. PubMed ID: 30704291 [TBL] [Abstract][Full Text] [Related]
18. Factors determining post-operative readmissions after left ventricular assist device implantation. Tsiouris A; Paone G; Nemeh HW; Brewer RJ; Morgan JA J Heart Lung Transplant; 2014 Oct; 33(10):1041-7. PubMed ID: 25034795 [TBL] [Abstract][Full Text] [Related]
19. Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy. Compostella L; Russo N; Setzu T; Compostella C; Bellotto F Artif Organs; 2014 May; 38(5):366-73. PubMed ID: 24117945 [TBL] [Abstract][Full Text] [Related]
20. Left ventricular assist devices and their complications: A review for emergency clinicians. Long B; Robertson J; Koyfman A; Brady W Am J Emerg Med; 2019 Aug; 37(8):1562-1570. PubMed ID: 31072684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]